Member Info for doggo

Look after yourselves ODONNELL clan. Personally I only share the fairly reasonable stuff...plenty I won’t.

LifeMap Sciences, a subsidiary of AgeX Therapeutics, Inc., announced today that it will be presenting its novel whole genome sequencing (WGS) interpretation solutions at Precision Medicine World Conference 2019 in Silicon Valley, on January 22nd,

Next news..,Intensity...

Yes we haven’t gone up every day therefore Factom doesn’t exist

They receive equity

Vemo is potentially the biggest in the PF. Anyone who’s been on this board long enough knows it’s my favourite

Intensity sale at huge premium

Agree

Always find a reason to sell. A steady price rise is NOT a reason to sell.

They will kick themselves and wonder why they are never holding a big mover when it makes the move. Price rise last few days is IMO ex-holders buying in for the Q1 flood of news.

I keep pointing out SP to historical NAV is still at a 30% discount....

Wonder what trash they are buying with their spoils?

And this gets interesting

Well worth reading this
https://www.linxens.com/dloc/ realise who their partners are...then ask why are Chinese chip maker Tsinghua Unigroup buying Linxens for $2.6bn

8 Yooya IPO/trade sale
9 Factom DHS

Sorry that’s 7 different news items that 4 of us are waiting for...

Any more?

Chils that 6 DIFFERENT news items that 3 of us are waiting for that are foremost in our minds

The news I’m looking forward to are Vemo series B and JUV Series B closing...

Very true Preds

We are still unbelievably 3.25p below historical SP V NAV.

PF about to start spilling

Why buy #FFWD?

Currently trading at a 40% discount to where historically they trade relative to NAV...

Any of the following near term Q1 events will seriously increase the NAV...

No European companies within PF so will be unaffected by BREXIT

Upcoming Events Q1

Any of these events will have a huge impact on NAV & SP...
Factom series B plus Lead Investor reveal
Factom 30+ NDAs to be revealed
Factom DHS
Vemo series B
Intensity news
Intensity sale?
Leap sale?
JUV series B, IPO & listing
Insilico series B
Yooya IPO/sale?
Emmac?

DATE. NAV SP
Dec 16 half year 7.9 10.2
July 17 full year results 7.6 10.2
Dec 17 half year 9.18 13.88
July 18 full year results 10.18 13.13
Dec 18 half year 11.40 10

Let’s look at the evidence..
*Peter Saladino Bought 9.37% of FFWD for 17.6p expressly for FACTOM
*Leap got a multinational strategic investor IMG who acquired 25%, FFWD increased their holding to 47%
*took part in Intensity series B maintaining their %. Intensity results their lead drug has been shown to shrink cancer tumours in humans. From a related parties investor file for series B, they expect either an IPO, outright sale or Big Pharma partnership.
*invested a further $6 million into Factom at a value of $8 million. Factom await phase 4 results from field testing with US Department of Homeland Security, await series B closing, await 30+ NDAs to be revealed with Fortune 100 & Fortune 1000 companies. Still continue to work with the Bill Gates Foundation.
*Vogogo now mining 1% of the total worldwide Bitcoin
*Juvenescence to IPO Q1 and starting series B funding imminently
*Yooya majority SH expect to see several IPO/trade sales within their PF

That is no longer the actual NAV and we are ridiculously oversold